Compliance to live oral Ty21a typhoid vaccine, and its effect on viability.

BACKGROUND Concerns have been expressed that in travelers the efficacy of the live oral Ty21a typhoid vaccine Vivotif could be lower than reported, maybe due to a lack of compliance. The purpose of this study was to examine the level of compliance with the recommendations regarding dosing, timing of dosing with respect to food intake, and storage. METHODS Travelers were randomized into two groups: one received oral information only, and the second, a combination of oral and written information. Four criteria of compliance were applied to travelers: 3 capsules needed to be swallowed (criterion 1) on day 1, 3 and 5 (criterion 2), at least 1 hour before or 2 hours after a meal (criterion 3) and the vaccine had to be kept refrigerated (2-8 degrees C) (criterion 4). Compliance was evaluated using three different methods: a questionnaire, pill counting, and electronic monitoring using the Medication Event Monitoring System (MEMS). Storage conditions were checked by temperature tags, and viability of the vaccine was assessed by culturing the content of remaining capsules. RESULTS The data of 115 travelers were analyzed. All the travelers took the 3 capsules. Compliance to all four criteria was complete in 68% of travelers according to the questionnaire, and 53% according to the MEMS (p =.05). Sixty-seven percent of all the doses intervals were of 48 hours +/- 6 hours, 12% being shorter than 36 hours and 7% longer than 60 hours. Eighty-seven travelers (76%) took their capsules on each alternate day. The method of information had no significant impact on compliance. Forty-two percent of tags showed exposure to temperature over 10 degrees C for more than 24 hours. Yet, no difference could be found in the viability of the vaccine compared with controls. CONCLUSIONS Most travelers take their 3 capsules on alternate days, but many did not follow the other recommendations. Electronic monitoring of compliance provides more accurate results than questionnaires. Emphasis must be put on motivating the travelers to take the vaccine as recommended.

[1]  P. Rogers.  Prescription Medicine Compliance: A Review of the Baseline of Knowledge- A Report of the National Council on Patient Information and Education , 1996 .

[2]  R. Thapa,et al.  Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. , 1987, The New England journal of medicine.

[3]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[4]  S. Singh,et al.  Blood-films int eh diagnosis of malaria , 1989 .

[5]  Joyce A. Cramer,et al.  Patient Compliance in Medical Practice and Clinical Trials , 1991 .

[6]  M. Falagas,et al.  Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity , 1998, BMJ.

[7]  W. P. Munroe,et al.  Impact of an Electronic Medication Compliance Aid on Long‐Term Blood Pressure Control , 1992, Journal of clinical pharmacology.

[8]  S. Hoffman,et al.  Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine , 1991, The Lancet.

[9]  S. Cryz.  Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a. , 1998, Journal of travel medicine.

[10]  R. Black,et al.  LARGE-SCALE FIELD TRIAL OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULE FORMULATION , 1987, The Lancet.

[11]  C. Serié,et al.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results. , 1982, Journal of Infectious Diseases.

[12]  B. Mason,et al.  Pharmacists' Interventions Using an Electronic Medication-Event Monitoring Device'S Adherence Data versus Pill Counts , 1993, The Annals of pharmacotherapy.

[13]  D. Hill,et al.  Compliance with live, oral Ty21a typhoid vaccine. , 1992, JAMA.

[14]  R. Wit,et al.  How often is medication taken as prescribed , 1993 .

[15]  Judith A. Hall,et al.  Effectiveness of interventions to improve patient compliance: a meta-analysis. , 1998, Medical care.

[16]  M. Burnier,et al.  Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  R. Schneerson,et al.  PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER , 1987, The Lancet.

[18]  K. A. McKibbon,et al.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications , 1996, The Lancet.

[19]  P D Mullen,et al.  Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types. , 1985, Preventive medicine.

[20]  M. Levine,et al.  Progress in vaccines against typhoid fever. , 1989, Reviews of infectious diseases.

[21]  M. Wolfe.  Precautions with oral live typhoid (Ty 21a) vaccine , 1990, The Lancet.

[22]  T. Pullar,et al.  Time to stop counting the tablets? , 1989, Clinical pharmacology and therapeutics.

[23]  J. Cramer,et al.  How often is medication taken as prescribed? A novel assessment technique. , 1989, JAMA.

[24]  W. Barr,et al.  Use of oral typhoid vaccine strain Ty21a in a New York state travel immunization facility. , 1993, The American journal of tropical medicine and hygiene.